Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer

Clinical trial NCT05072600 · RECRUITING

Trial details

NCT number: NCT05072600
Sponsor: Peking University First Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Bladder Neoplasms Bladder Tumors Urinary Bladder Cancer Neoplasms, Bladder

Start date: 2021-12-07
Primary completion: 2024-12-07
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.